Publikationen in Zusammenarbeit mit Forschern von Universidad Complutense de Madrid (2)

2020

  1. Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study

    Neuroendocrinology, Vol. 110, Núm. 1-2, pp. 50-62

2012

  1. Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

    PLoS ONE, Vol. 7, Núm. 10